With an NIH Pioneer Award, UF Researcher Targets Common Infection
UF researcher Ivana Parker is targeting one of the most common and dangerous infections in women, backed by a $2.7 million grant from the National Institutes of Health.
Wertheim UF Scripps Institute Scientists Find Potential Cellular Target for HIV Therapies
Researchers at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology have discovered a protein that appears to play a key role in helping HIV replicate in human immune cells, providing more clues about how cellular machinery allows the virus to create new copies of itself.
HIV Drug Shows Potential To Combat Genetic Form of Dystonia in Preclinical Study
A new UF study found that an FDA-approved medication to treat HIV restored multiple brain abnormalities in a mouse model of a genetic form of dystonia.
etectRx Announces Launch of MyTPill Study To Address Medication Adherence Among HIV+ Prescription Opioid Users
UF Innovate | The Hub resident company etectRx, Inc., a privately-held digital health company, announced the launch of a study to monitor antiretroviral therapy adherence among prescription opioid users living with HIV.
